Acurx Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACXP Nasdaq 2836 www.acurxpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Jan 7th, 2025 10:00 pm
Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Jan 6th, 2025 10:35 pm
Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI) - Jan 6th, 2025 1:30 pm
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year? - Jan 3rd, 2025 2:40 pm
Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025 - Dec 11th, 2024 4:00 pm
Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications - Dec 9th, 2024 1:00 pm
Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now - Nov 28th, 2024 2:55 pm
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025 - Nov 27th, 2024 12:00 pm
MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000 - Nov 22nd, 2024 5:25 pm
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset - Nov 20th, 2024 12:01 pm
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update - Nov 18th, 2024 12:00 pm
Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Nov 14th, 2024 7:07 am
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update - Nov 13th, 2024 12:00 pm
New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week" - Oct 31st, 2024 7:00 pm
New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH) - Oct 28th, 2024 2:00 pm
Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference - Oct 21st, 2024 11:00 am
Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement - Oct 17th, 2024 12:00 pm
Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024 - Oct 16th, 2024 12:00 pm
New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support - Oct 14th, 2024 5:00 pm
New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST - Oct 11th, 2024 3:05 pm